|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.545 USD | -3.71% |
|
-8.73% | -76.98% |
| 07-30 | Curis, Inc. Doses First Five Patients in TakeAim CLL Study | CI |
| 07-22 | Curis, Inc. - Special Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 11.34 | 11.34 | 11.34 |
| Spread/Res. | -59.92% | -59.92% | -59.92% |
| Spread/Supp. | +10.42% | +10.42% | +124.00% |
| Support | 4.116 | 4.116 | 2.029 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CRIS Stock
- Charts Curis, Inc.
Select your edition
All financial news and data tailored to specific country editions
